Abstract
Radiation and some chemotherapeutic agents used in conventional cancer treatment generate reactive oxygen species (ROS), and a high ROS level diminishes cellular antioxidant capacity and leads to apoptosis and cancer cell death. Antioxidant supplements are consumed widely by cancer patients in order to prevent toxic side effects of cancer treatment to normal tissues and organs. However, the effects of antioxidant supplementation in cancer therapy were largely disappointing. There is still no consensus on the efficacy and safety of dietary antioxidant supplementation during conventional cancer therapy. In some studies, antioxidant supplements did not reduce the risk for cancer or prevent tumour growth; at the contrary, these interventions resulted in some cases to be harmful to the patients. Therefore, a guidance on antioxidant supplementation based on large clinical trials is urgently needed in order to obtain the best possible care and to avoid risky treatments for cancer patients.
Keywords: Antioxidants, Cancer, Chemotherapeutic agents, Oxidative stress, Radiation, Reactive oxygen species, Supplements.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Antioxidant Supplementation on Cancer Risk and During Cancer Therapy: An Update
Volume: 15 Issue: 2
Author(s): Tomris Ozben
Affiliation:
Keywords: Antioxidants, Cancer, Chemotherapeutic agents, Oxidative stress, Radiation, Reactive oxygen species, Supplements.
Abstract: Radiation and some chemotherapeutic agents used in conventional cancer treatment generate reactive oxygen species (ROS), and a high ROS level diminishes cellular antioxidant capacity and leads to apoptosis and cancer cell death. Antioxidant supplements are consumed widely by cancer patients in order to prevent toxic side effects of cancer treatment to normal tissues and organs. However, the effects of antioxidant supplementation in cancer therapy were largely disappointing. There is still no consensus on the efficacy and safety of dietary antioxidant supplementation during conventional cancer therapy. In some studies, antioxidant supplements did not reduce the risk for cancer or prevent tumour growth; at the contrary, these interventions resulted in some cases to be harmful to the patients. Therefore, a guidance on antioxidant supplementation based on large clinical trials is urgently needed in order to obtain the best possible care and to avoid risky treatments for cancer patients.
Export Options
About this article
Cite this article as:
Ozben Tomris, Antioxidant Supplementation on Cancer Risk and During Cancer Therapy: An Update, Current Topics in Medicinal Chemistry 2015; 15 (2) . https://dx.doi.org/10.2174/1568026615666141209160918
DOI https://dx.doi.org/10.2174/1568026615666141209160918 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Redox-Driven Events in the Human Immunodeficiency Virus Type 1 (HIV-1) Infection and their Clinical Implications
Current HIV Research Proteomics to Identify Novel Biomarkers and Therapeutic Targets in Cardiovascular Disease
Letters in Drug Design & Discovery Vascular Oxidative Stress: A Key Factor in the Development of Hypertension Associated with Ethanol Consumption
Current Hypertension Reviews Sympathetic Overactivity in Hypertension and Cardiovascular Disease
Current Vascular Pharmacology Protein Factors Mediating Selenoprotein Synthesis
Current Protein & Peptide Science Patterns of Self-Medication with Medicinal Plants and Related Adverse Events - A South American Survey
Current Drug Safety Pharmacologically Targeting the Primary Defect and Downstream Pathology in Duchenne Muscular Dystrophy
Current Gene Therapy Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Current Pharmaceutical Design Targeting Cardiomyocyte Ca<sup>2+</sup> Homeostasis in Heart Failure
Current Pharmaceutical Design PET Imaging of Beta-Adrenoceptors in Human Brain: A Realistic Goal or a Mirage?
Current Pharmaceutical Design Association of Viruses in the Development of Cardiovascular Diseases
Current Pharmaceutical Design Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Diabetic Retinopathy: Mechanistic Insights into High Glucose-Induced Retinal Cell Death
Current Clinical Pharmacology Hyperpolarized Metabolic MR in the Study of Cardiac Function and Disease
Current Pharmaceutical Design The Failure of Immunomodulation Therapy in Heart Failure: Does the Statins “Paradigm” Prove the Rule?
Current Vascular Pharmacology Urinary Steroids Measured by Modern Separation Techniques and Applied as Biomarkers in Stress Studies
Current Pharmaceutical Analysis Cardiac Tissue Engineering
Recent Patents on Regenerative Medicine Molecular Basis of Antiretroviral Drugs-Associated Long-Term Toxicity: How Bad can Good Drugs Be?
Current Medicinal Chemistry - Anti-Infective Agents ULK1 Plays a Critical Role in AMPK-Mediated Myocardial Autophagy and Contractile Dysfunction following Acute Alcohol Challenge
Current Pharmaceutical Design Prospectives of Antihypertensive Nano-ceuticals as Alternative Therapeutics
Current Drug Targets Impact of COVID-19 Infection on Maternal and Neonatal Outcomes: A Review of 11078 Pregnancies Reported in the Literature
Current Women`s Health Reviews